MarketCapTrends
LXRX
Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare

Lexicon Pharmaceuticals, Inc. Long Term Debt 2009–2025

Lexicon Pharmaceuticals, Inc. annual/quarterly long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Lexicon Pharmaceuticals, Inc. long term debt for the quarter ending December 31, 2025 were 49.4M, a 50.74% decrease year-over-year.
  • Lexicon Pharmaceuticals, Inc. long term debt for 2025 were 49.4M, a 50.74% decrease from 2024.
  • Lexicon Pharmaceuticals, Inc. long term debt for 2024 were 100.3M, a 0.79% increase from 2023.
  • Lexicon Pharmaceuticals, Inc. long term debt for 2023 were 99.5M, a 104.75% increase from 2022.
  • Lexicon Pharmaceuticals, Inc. long term debt for 2022 were 48.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Lexicon Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $)
2025$49
2024$100
2023$100
2022$49
2019$249
2018$250
2017$252
2016$101
2015$106
2014$108
2013$22
2012$23
2011$23
2010$27
Lexicon Pharmaceuticals, Inc. Quarterly Long Term Debt (Millions of US $)
2025-12-31$49
2024-12-31$100
2023-12-31$100
2022-12-31$49
2019-12-31$249
2018-12-31$250
2017-12-31$252
2016-12-31$101
2015-12-31$106
2014-12-31$108
2013-12-31$22
2012-12-31$23
2011-12-31$23
2010-12-31$27

Lexicon Pharmaceuticals, Inc. Long Term Debt — FAQ

Lexicon Pharmaceuticals, Inc. (LXRX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LXRX's long term debt history?

The chart and table above show Lexicon Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.